Random Forest Algorithm in Unravelling Biomarkers of Breast Cancer Progression

Nadiia Kasianchuk, Dmytro Tsvyk, Eduard Siemens and Halina Falfushynska

References:

1. S.C. Shah, V. Kayamba, R.M. Jr. Peek, and D. Heimburger, “Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening?” vol. 5, pp. 1-8, 2019, doi: 10.1200/JGO.18.00200.
2. J. Li, X. Guan, and et al., “Non-Invasive Biomarkers for Early Detection of Breast Cancer,” Cancers (Basel), vol. 12(10), pp. 2767, 2020, doi: 10.3390/cancers12102767.
3. B.K. Banin Hirata, J.M. Oda, R. Losi Guembarovski, C.B. Ariza, C.E. de Oliveira, and M.A. Watanabe, “Molecular markers for breast cancer: prediction on tumor behavior,” Dis. Markers, vol. 2014, pp. 513158, 2014, doi: 10.1155/2014/513158.
4. A.N. Richter and T.M. Khoshgoftaar, “A review of statistical and machine learning methods for modeling cancer risk using structured clinical data,” Artif. Intell. Med., vol. 90, pp. 1-14, 2018, doi: 10.1016/j.artmed. 2018.06.002.
5. A. Zaremba, P. Zaremba, S. Siry, Y. Shermolovich, and S. Zagorodnya, “In vitro and in silico study of anti-influenza activity of 2-dioxopyrimidin-5-trifluoromethyl-tetrahydrothiophene with subsequent increase in its affinity for the target protein,” Proceedings of the 7th International Electronic Conference on Medicinal Chemistry, 1-30 November 2021, MDPI: Basel, Switzerland, doi:10.3390/ ECMC2021-11439.
6. L. Peng, W. Chen, W. Zhou, F. Li, J. Yang, and J. Zhang, “An immune-inspired semi-supervised algorithm for breast cancer diagnosis,” Comput. Methods Programs Biomed., vol. 134, pp. 259-265, 2016, doi: 10.1016/j.cmpb.2016.07.020.
7. H. Falfushynska, O. Lushchak, and E. Siemens, “The Application of Multivariate Statistical Methods in Ecotoxicology and Environmental Biochemistry,” Proceedings of International Conference on Applied Innovation in IT, vol. 10 (1), pp. 99-104, 2022.
8. P. Rzymski, N. Kasianchuk, D. Sikora, and B. Poniedziałek, “COVID‐19 Vaccinations and Rates of Infections, Hospitalizations, ICU Admissions, and Deaths in Europe during SARS‐CoV‐2 Omicron wave in the first quarter of 2022,” Journal of Medical Virology, vol. 95(14), 2022, doi: 10.1002/jmv.28131.
9. P.S. Rana, A. Alkrekshi, W. Wang, V. Markovic, and K. Sossey-Alaoui, “The Role of WAVE2 Signaling in Cancer”, Biomedicines, vol. 9(9), pp. 1217, 2021, doi: 10.3390/biomedicines9091217.
10. Y.H. Kuo, A.L. Shiau, and et al., “Expression of prothymosin α in lung cancer is associated with squamous cell carcinoma and smoking”, Oncol. Lett., vol. 17(6), pp. 5740-5746, 2019, doi: 10.3892/ol.2019.10248.
11. S. Roy, S. Saha, and et al., “Molecular crosstalk between CUEDC2 and ERα influences the clinical outcome by regulating mitosis in breast cancer”, Cancer Gene Ther., vol. 29(11), pp. 1697-1706, 2022, doi: 10.1038/s41417-022-00494-x.
12. C. Tao, W. Liu, and et al., “PAQR5 Expression Is Suppressed by TGFβ1 and Associated With a Poor Survival Outcome in Renal Clear Cell Carcinoma”, Front. Oncol., vol. 11, pp. 827344, 2022, doi: 10.3389/fonc.2021.827344.
13. X. Chen and H. Ishwaran, “Random forests for genomic data analysis,” Genomics, vol. 99(6), pp. 323-9, 2012, doi: 10.1016/j.ygeno.2012.04.003.
14. N.E. Reticker-Flynn, W. Zhang, and et al., “Lymph node colonization induces tumor-immune tolerance to promote distant metastasis”, Cell, vol. 185(11), pp. 1924-1942.e23, 2022, doi: 10.1016/j.cell.2022. 04.019.
15. Y. Song, K. Sun, and et al., “CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer”, Med. Oncol., vol. 40(1), pp. 62, 2022, doi: 10.1007/s12032-022-01919-1.
16. Y. Zhou, Y. Che, Z. Fu, H. Zhang, and H. Wu, “Triple-Negative Breast Cancer Analysis Based on Metabolic Gene Classification and Immunotherapy”, Front. Public Health, vol. 10, pp. 902378, 2022, doi: 10.3389/fpubh.2022.902378.
17. V.A. Kraft, C.T. Bezjian, and et al., “GTP Cyclohydrolase 1/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling”, ACS Cent Sci. vol. 6(1), pp. 41-53, 2020, doi: 10.1021/acscentsci.9b01063.
18. M. Saxena, R.K.R. Kalathur, and et al., “2-Histone Interaction Is Critical for Cancer Cell Dedifferentiation and Progression in Malignant Breast Cancer”, Cancer Res. vol. 80(17), pp. 3631-3648, 2020, doi: 10.1158/0008-5472.CAN-19-2910.
19. S. Satheesha, V.J. Cookson, and et al., “Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer”, Mol. Cancer, vol. 10, pp. 19, 2011, doi: 10.1186/1476-4598-10-19.
20. L. Li, X. Liu, L. He, and et al., “ZNF516 suppresses EGFR by targeting the CtBP/LSD1/CoREST complex to chromatin”, Nat. Commun., vol. 8(1), pp. 691, 2017, doi: 10.1038/s41467-017-00702-5.